Concepedia

T. A. Pursiano

TA

13

Publications

645

Citations

11

H-Index

1961

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol Laboratories (United Kingdom)

T. A. Pursiano is an author at Bristol-Myers Squibb (United States) specializing in medicine, antibiotics, and microbiology.

Top concepts

Publications per year

1961–1987

13

Publications

13

Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics

R E Kessler, M Bies, R. E. Buck et al. · Antimicrobial Agents and Chemotherapy · 1985 · 159 citations

, , +15

Activity of BB-K8 (Amikacin) Against Clinical Isolates Resistant to One or More Aminoglycoside Antibiotics

K. E. Price, T. A. Pursiano, M. D. DeFuria et al. · Antimicrobial Agents and Chemotherapy · 1974 · 107 citations · Full text

Amikacin, an Aminoglycoside with Marked Activity against Antibiotic-Resistant Clinical Isolates

K. E. Price, M. D. DeFuria, T. A. Pursiano · The Journal of Infectious Diseases · 1976 · 98 citations

, , +15

BMY 28100, a new oral cephalosporin

F. Leitner, T. A. Pursiano, R. E. Buck et al. · Antimicrobial Agents and Chemotherapy · 1987 · 62 citations

, , +15

Laboratory Evaluation of BL-S786, a Cephalosporin with Broad-Spectrum Antibacterial Activity

F. Leitner, M Misiek, T. A. Pursiano et al. · Antimicrobial Agents and Chemotherapy · 1976 · 48 citations · Full text

Rows per page

1–5 of 13